Blocking the CoQ-FSP1 axis renders KEAP1-mutant lung cancer cells more vulnerable to radiation therapy by triggering ferroptosis, indicating FSP1 as a promising therapeutic target for combating treatment resistance in these malignancies (Koppula et al., 2022). This evidence concerns the gene KEAP1 and lung carcinoma.